Terkko Navigator / Clinical Medicine/ Feeds

Left Lateral Cervical Mass with Draining Sinuses.

Sodium Oxybate: A Cause of Extreme Involuntary Weight Loss in a Young Lady.

Spontaneous bleeding of the inferior pancreatic-duodenal artery in median arcuate ligament syndrome: do not miss the diagnosis.

'IVC contrast level: a sign of cardiovascular dysfunction'.

Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion: a case report.

Diagnosing Sepsis: QSOFA is Not the Tool We’re Looking For

Innovative solutions and Insights to Phlebitis Prevention

Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients?

Losing my mind: an uncommon presentation of Cushing’s disease

A man with a clot on his platelets - adrenal carcinoma with complete caval thrombosis causing dynamic right ventricular inflow obstruction

Immunoinflammatory responses to febrile lower respiratory infections in infants display uniquely complex/intense transcriptomic profiles

Prenatal Oxidative Balance and Risk of Asthma and Allergic Disease in Adolescence

CD23 provides a non-inflammatory pathway for IgE-allergen complexes

Determinants of long-lasting insecticidal net ownership and utilization in malaria transmission regions: evidence from Zimbabwe Demographic and Health Surveys

Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial

Which place for avelumab in the management of urothelial carcinoma?

Pembrolizumab for the treatment of cervical cancer

Pembrolizumab for the treatment of head and neck squamous cell cancer

γδ cell-based immunotherapy for cancer

Immunotherapy for renal cell carcinoma

Why do we need to improve monitoring of patients with inflammatory bowel disease (IBD) on biologic treatment?

Immunotherapy and biologicals for the treatment of allergy to Hymenoptera stings

Durvalumab in cancer medicine: a comprehensive review

An update on therapies for the treatment of diabetes-induced osteoporosis

Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS

Biologics for the treatment of adult-onset still’s disease

Immunotherapeutic approaches in nasopharyngeal carcinoma

Curcumin: footprints on cardiac tissue engineering

Selected application of peptide molecules as pharmaceutical agents and in cosmeceuticals

Induced pluripotent stem cells as a novel cancer vaccine

The fall and rise of phage therapy in modern medicine

Inflammatory cytokines: from discoveries to therapies in IBD

Long-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active rheumatoid arthritis: results from a phase 3b extension study (VOLTAIRE-RAext)

Immune therapy, a double-edged sword for oncolytic viruses

Do biomarkers play a predictive role for response to novel immunotherapeutic agents in metastatic renal cell carcinoma?

Caplacizumab: a change in the paradigm of thrombotic thrombocytopenic purpura treatment

Chimeric antigen receptor T-cell therapy for the treatment of aggressive B-cell non-Hodgkin lymphomas: efficacy, toxicity, and comparative chimeric antigen receptor products

B cell maturation antigen (BCMA)-based immunotherapy for multiple myeloma

Biosimilars for breast cancer

Population pharmacokinetics of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderately to severely active rheumatoid arthritis

Biosimilars for the treatment of psoriasis

Switching to biosimilars: current perspectives in immune-mediated inflammatory diseases

Differences in immunogenicity associated with non-product related variability: insights from two pharmacokinetic studies using GP2017, an adalimumab biosimilar

GP2017, an adalimumab biosimilar: pharmacokinetic similarity to its reference medicine and pharmacokinetics comparison of different administration methods

The role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases

Biosimilars of adalimumab: the upcoming challenge in IBD

Bioequivalence studies with anti-TNF biosimilars

Mechanism of action of the trastuzumab biosimilar CT-P6

Differentiation of skin incision and laparoscopic trocar insertion via quantifying transient bradycardia measured by electrocardiogram

DynaMed Plus App Review